Log in to Thinknum

Interested in Thinknum?

Request a demo

LinkedIn Profile

Access Accelerate Diagnostics historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Ticker Sector Ticker Industry
nasdaq:axdx 2921028 May 21st, 2019 12:00AM Accelerate Diagnostics 3.6K 231.00 Open Medical Devices May 21st, 2019 10:19AM May 21st, 2019 10:19AM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 20th, 2019 12:00AM Accelerate Diagnostics 3.6K 231.00 Open Medical Devices May 19th, 2019 10:10PM May 19th, 2019 10:10PM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 19th, 2019 12:00AM Accelerate Diagnostics 3.6K 231.00 Open Medical Devices May 19th, 2019 03:32PM May 19th, 2019 03:32PM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 18th, 2019 12:00AM Accelerate Diagnostics 3.6K 230.00 Open Medical Devices May 18th, 2019 10:32AM May 18th, 2019 10:32AM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 17th, 2019 12:00AM Accelerate Diagnostics 3.6K 230.00 Open Medical Devices May 17th, 2019 04:06PM May 17th, 2019 04:06PM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 16th, 2019 12:00AM Accelerate Diagnostics 3.6K 231.00 Open Medical Devices May 15th, 2019 10:10PM May 15th, 2019 10:10PM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 15th, 2019 12:00AM Accelerate Diagnostics 3.6K 231.00 Open Medical Devices May 15th, 2019 08:36AM May 15th, 2019 08:36AM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 14th, 2019 12:00AM Accelerate Diagnostics 3.6K 232.00 Open Medical Devices May 14th, 2019 09:09AM May 14th, 2019 09:09AM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 13th, 2019 12:00AM Accelerate Diagnostics 3.6K 231.00 Open Medical Devices May 12th, 2019 10:09PM May 12th, 2019 10:09PM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 May 12th, 2019 12:00AM Accelerate Diagnostics 3.6K 231.00 Open Medical Devices May 12th, 2019 01:41PM May 12th, 2019 01:41PM Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays. Open Diagnostics, Medical Devices, Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.